FR2790200B3 - Formulation stable contenant de la fumagilline - Google Patents

Formulation stable contenant de la fumagilline

Info

Publication number
FR2790200B3
FR2790200B3 FR9902401A FR9902401A FR2790200B3 FR 2790200 B3 FR2790200 B3 FR 2790200B3 FR 9902401 A FR9902401 A FR 9902401A FR 9902401 A FR9902401 A FR 9902401A FR 2790200 B3 FR2790200 B3 FR 2790200B3
Authority
FR
France
Prior art keywords
formulation containing
stable formulation
fumagillin
containing fumagillin
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9902401A
Other languages
English (en)
Other versions
FR2790200A1 (fr
Inventor
Bernard Abramovici
Jean Luc Dubois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9902401A priority Critical patent/FR2790200B3/fr
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to AU28114/00A priority patent/AU2811400A/en
Priority to AT00906438T priority patent/ATE361757T1/de
Priority to DK00906438T priority patent/DK1156829T3/da
Priority to HU0202151A priority patent/HU228857B1/hu
Priority to ES00906438T priority patent/ES2286998T3/es
Priority to PCT/FR2000/000424 priority patent/WO2000050084A1/fr
Priority to JP2000600694A priority patent/JP2002537358A/ja
Priority to US09/913,547 priority patent/US6528539B1/en
Priority to EP00906438A priority patent/EP1156829B1/fr
Priority to SI200030959T priority patent/SI1156829T1/sl
Priority to DE60034770T priority patent/DE60034770T2/de
Priority to PT00906438T priority patent/PT1156829E/pt
Publication of FR2790200A1 publication Critical patent/FR2790200A1/fr
Application granted granted Critical
Publication of FR2790200B3 publication Critical patent/FR2790200B3/fr
Anticipated expiration legal-status Critical
Priority to CY20071101062T priority patent/CY1106807T1/el
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9902401A 1999-02-26 1999-02-26 Formulation stable contenant de la fumagilline Expired - Lifetime FR2790200B3 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR9902401A FR2790200B3 (fr) 1999-02-26 1999-02-26 Formulation stable contenant de la fumagilline
SI200030959T SI1156829T1 (sl) 1999-02-26 2000-02-21 Stabilna formulacija, ki vsebuje fumagilin
DK00906438T DK1156829T3 (da) 1999-02-26 2000-02-21 Stabil formulering indeholdende fumagillin
HU0202151A HU228857B1 (en) 1999-02-26 2000-02-21 Stable formulation containing fumagillin
ES00906438T ES2286998T3 (es) 1999-02-26 2000-02-21 Formulacion estable que contiene fumagillina.
PCT/FR2000/000424 WO2000050084A1 (fr) 1999-02-26 2000-02-21 Formulation stable contenant de la fumagilline
JP2000600694A JP2002537358A (ja) 1999-02-26 2000-02-21 フマギリンを含有する安定な製剤
US09/913,547 US6528539B1 (en) 1999-02-26 2000-02-21 Stable formulation containing fumagillin
AU28114/00A AU2811400A (en) 1999-02-26 2000-02-21 Stable formulation containing fumagillin
AT00906438T ATE361757T1 (de) 1999-02-26 2000-02-21 Stabile fumagillin-formulierung
DE60034770T DE60034770T2 (de) 1999-02-26 2000-02-21 Stabile fumagillin-formulierung
PT00906438T PT1156829E (pt) 1999-02-26 2000-02-21 ''formulação estável contendo fumagilina''
EP00906438A EP1156829B1 (fr) 1999-02-26 2000-02-21 Formulation stable contenant de la fumagilline
CY20071101062T CY1106807T1 (el) 1999-02-26 2007-08-08 Σταθερη συνθεση που περιεχει φουμαγιλλινη

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9902401A FR2790200B3 (fr) 1999-02-26 1999-02-26 Formulation stable contenant de la fumagilline

Publications (2)

Publication Number Publication Date
FR2790200A1 FR2790200A1 (fr) 2000-09-01
FR2790200B3 true FR2790200B3 (fr) 2001-06-01

Family

ID=9542568

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9902401A Expired - Lifetime FR2790200B3 (fr) 1999-02-26 1999-02-26 Formulation stable contenant de la fumagilline

Country Status (1)

Country Link
FR (1) FR2790200B3 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0212299B1 (pt) * 2001-09-10 2016-03-15 Hoffmann La Roche veículo tixotrópico oleoso, seu processo de preparação, massa de enchimento, e dose unitária farmacêutica
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor

Also Published As

Publication number Publication date
FR2790200A1 (fr) 2000-09-01

Similar Documents

Publication Publication Date Title
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
MA24466A1 (fr) Compositions contenant de la tetrahydrolistatine
PT853945E (pt) Formulacoes liquidas contendo gonadotrofina
DK1052974T3 (da) Farmaceutisk sammensætning indeholdende epothilon
ID23299A (id) Formulasi-formulasi farmasi
DE60033021D1 (de) Strukturierte kosmetische zusammensetzungen
ITMI991754A0 (it) Composizioni cosmetiche
ID29468A (id) Komposisi farmasi yang stabil dalam bentuk liofil
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
ID28698A (id) Formulasi antiparasit
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
ATE401908T1 (de) Pharmazeutische zusammensetzungen von erythropoietin
DE69900561T2 (de) Pharmazeutische Zusammensetzungen enthaltend Mupirocin
ATE319461T1 (de) Simethicon enthaltendes abführmittel
DE69935609D1 (de) Formulierungen enthaltend cefuroxim-axetil
ID27655A (id) Formulasi mikrokapsul
DE10084344T1 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzung
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
NO20003105D0 (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
ID30032A (id) Formulasi farmasi
NO20002590D0 (no) Formuleringer omfattende oppløst paroxetin
DE60008839D1 (de) Duftstoff-Zusammensetzung
ID23928A (id) Formulasi mengandung insektisida
ATE297187T1 (de) Resorcinenthaltende zusammensetzung

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name